Related Experiment Video
Updated: Jul 11, 2026

Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
Clostridioides difficile-Derived Extracellular Vesicles Induce Proinflammatory Responses in Macrophages
Fangfang Fan1,2, Yu Zeng1,2, Qianli Zhao1
1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Clostridioides difficile extracellular vesicles (EVs) stimulate macrophage inflammation via FliC protein interacting with TLR5. Inhibiting this interaction reduces inflammatory responses, suggesting FliC as a therapeutic target for Clostridioides difficile infection.
Area of Science:
- Microbiology
- Immunology
- Cell Biology
Background:
- Clostridioides difficile (CD) causes significant antibiotic-associated diarrhea.
- Extracellular vesicles (EVs) are implicated in pathogen-host interactions.
Purpose of the Study:
- To investigate the role of Clostridioides difficile strain 630-derived EVs (CD630-EVs) in modulating macrophage pro-inflammatory cytokine production.
- To identify key proteins within CD630-EVs responsible for immune modulation.
Main Methods:
- Proteomic analysis of CD630-EVs.
- In vitro stimulation of mouse macrophages with CD630-EVs.
- Measurement of cytokine production (IL-6, MCP-1, IL-1α, TNF-α).
- Inhibition studies using a flagellin receptor inhibitor (TH1020) and protein docking analysis.
Main Results:
- CD630-EVs contain 1064 proteins, including immune-related proteins FliC, TrxA, TrxA2, and HtpG, with FliC being highly expressed.
- CD630-EVs significantly increased pro-inflammatory cytokine production in macrophages.
- TH1020 inhibited cytokine production by disrupting the FliC-TLR5 interaction.
- FliC appears to be a key mediator of CD630-EV-induced inflammation via TLR5 activation.
Conclusions:
- CD630-EVs modulate macrophage inflammatory responses during Clostridioides difficile infection (CDI).
- FliC within CD630-EVs is a critical mediator of inflammation, potentially through TLR5 interaction.
- FliC represents a potential therapeutic target for mitigating intestinal mucosal injury in CDI.
More Related Videos
08:34Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Published on: February 22, 2017
10:09Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease